Clinical trials, traditionally plagued by low success rates and high operational costs, are being reengineered through AI ...

It is predicted that the first new drug developed by artificial intelligence (AI) may be commercialized in 2030. Alex ...

According to brokerage Jefferies, the average drug development cycle spans 8 to 10 years, with success rates below 10% and ...

Artificial intelligence and robotics are revolutionizing drug discovery by automating laboratory processes and enabling rapid ...

It is not surprising that President Trump issued a May 12, 2025 executive order, “Delivering Most-Favored-Nation Prescription ...

GATC Health Corp, a leading tech-bio company leveraging artificial intelligence (AI) to transform drug discovery, has ...

Experts said the president's executive order could work in lowering costs, but it won't make for an immediate fix.

The president has signed an executive order stating that the US will institute a “most-favored-nation” policy, whereby the US will pay the same price for a drug as the nation that pays the lowest ...

An author of the Affordable Care Act explores what the federal push to lower prescription drug prices could do—and what it ...

President Donald Trump issued an executive order (EO) aimed at drastically reducing the cost of prescription drugs for ...

Experts said Trump’s action could lower the cost of prescription drugs, but they cautioned it's far from an immediate fix.

Kaddis said insurers are locked in a cat-and-mouse game with drugmakers as the insurance sector invests in biosimilars and ...